ADPT Exercise Disclosure
Rubinstein Julie · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$0
Rubinstein Julie President And COO
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
ADPT daily price context
Close on/before transaction
$26.64
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 11,881 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001780664-26-000049
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$1.36M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Sale | Nov 3, 2026 | $308.67K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Nov 3, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Nov 3, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Nov 2, 2026 | $234.54K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Nov 2, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Nov 2, 2026 | $68.09K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Nov 2, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 30, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 30, 2026 | $251.85K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 30, 2026 | $65.74K |
| Adaptive Biotechnologies Corp ADPT Current | Exercise | Oct 30, 2026 | $0 |